PDL BioPharma, Inc. PDLI announced today that it has completed the retirement of the remaining $133.5 million in aggregate principal of the Company's 2.00% Convertible Senior Notes, due February 15, 2012, for $133.9 million plus interest of $1.0 million.
With the completion of this redemption, no Notes remain outstanding.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
